← Back to Search

Exercise Training for Breast Cancer Survivors

N/A
Recruiting
Led By Demetra Christou, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female based on biological sex
Diagnosis of primary invasive non-metastatic breast cancer, stages I-III
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the 12 weeks of supervised exercise training
Awards & highlights

Study Summary

This trial may help reduce risk of heart disease for 3.8 million US breast cancer survivors through a novel exercise intervention. #CVD #breastcancer

Who is the study for?
This trial is for female breast cancer survivors, aged 40-80, who've completed chemotherapy for primary invasive non-metastatic breast cancer (stages I-III) 6-18 months prior. They must be cleared by a clinician and not engage in regular intense exercise. Excluded are those with severe obesity, ongoing radiation or surgery plans, recent other treatments or interventions that could affect results, and certain cardiovascular conditions.Check my eligibility
What is being tested?
The study tests the impact of a novel exercise program on heart health in breast cancer survivors post-chemotherapy. It aims to reduce cardiovascular disease risks through tailored cardiovascular rehabilitation exercises.See study design
What are the potential side effects?
Since this trial involves an exercise program designed for rehabilitation purposes, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue but should generally be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am biologically female.
Select...
My breast cancer is in stages I-III and has not spread to distant parts of the body.
Select...
I am between 40 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the 12 weeks of supervised exercise training
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the 12 weeks of supervised exercise training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
% completed vs. planned exercise duration
% completed vs. planned exercise frequency
% completed vs. planned exercise intensity
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Indoor RowingExperimental Treatment1 Intervention
Research participants will be instructed how to use a Concept 2 RowErg and will be provided instruction on basic rowing skills for beginners. Exercise training will gradually progress to 50 min of moderate-intensity exercise, on 3 days per week, for 12 weeks.
Group II: Usual CareActive Control1 Intervention
Research participants in this group will have the opportunity to complete the supervised indoor rowing program after completing their post-intervention assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise training
2019
Completed Phase 1
~1110

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,353 Previous Clinical Trials
723,438 Total Patients Enrolled
14 Trials studying Breast Cancer
591 Patients Enrolled for Breast Cancer
Demetra Christou, PhDPrincipal InvestigatorUniversity of Florida
7 Previous Clinical Trials
377 Total Patients Enrolled
2 Trials studying Breast Cancer
226 Patients Enrolled for Breast Cancer

Media Library

Exercise training Clinical Trial Eligibility Overview. Trial Name: NCT05848141 — N/A
Breast Cancer Research Study Groups: Indoor Rowing, Usual Care
Breast Cancer Clinical Trial 2023: Exercise training Highlights & Side Effects. Trial Name: NCT05848141 — N/A
Exercise training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05848141 — N/A
~48 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top